Compare — Georgia Financials

panel 2026-09-21Ask

Pooled trend

5 companies

Aggregate by year

GEL, thousands · money Σ · ratios from summed bases · growth on the pooled series

Metric	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024
Revenue	16,476	44,971	51,078	50,488	67,646	66,508	77,615
EBITDA	1,967	10,240	13,858	10,208	11,244	7,213	10,668
Net profit	1,933	10,099	14,234	9,630	10,092	6,510	6,353
Total assets	14,273	17,334	20,270	29,617	42,880	38,115	41,515
n (companies reporting)	3	4	4	5	5	5	5

Per-company contribution by year

XLSX

GEL, thousands

Company	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024
Medel Sakartvelo	—	18,187	14,053	8,010	8,444	5,326	16,323
Neoparmi +	11,739	13,331	16,551	16,799	18,348	13,883	16,295
Jihelsi	—	—	—	0	10,134	11,128	15,588
Tbilisi Medic	4,737	7,989	13,889	15,106	12,433	14,301	14,805
New Pharma	0	5,465	6,587	10,573	18,287	21,871	14,604

Rows are the raw pool — every peer, including any excluded from the sums above, so the de-duplication stays auditable. Tinted cells are the excluded company-years.

Peer coverage varies by year — FY2018–FY2021 pool fewer than the 5 picked companies (see the n row). A year is never dropped because one peer is missing.

Pooled figures sum every peer in the set. Known parent/subsidiary groups that file separately are de-duplicated; groups not yet curated may still be counted more than once.